A recent study published in Health Care for Women International highlights significant concerns regarding electroconvulsive therapy. The research, which surveyed 858 participants across 44 countries, suggests that women are more likely to experience negative outcomes and side effects compared to their male counterparts. These outcomes frequently include both short-term and long-term memory loss, with some participants reporting a lack of clarity regarding the consent process and the severity of potential risks.
Lisa Morrison, a co-author of the study, shares her own history with the procedure. After undergoing multiple series of treatments, she reports losing memory of entire years of her life. Her experience mirrors that of other public figures, including Paris Jackson, who recently detailed her own treatment journey. Jackson noted that while the procedure was intended to address severe mental health struggles, the physical pain and cognitive side effects were significant factors in her assessment of the process.
The study underscores a critical discrepancy in how these treatments are administered and perceived. Data indicates that women are twice as likely to receive this treatment as men. Furthermore, the authors point to a disconnect where procedures are often prescribed without addressing underlying factors such as trauma or environmental abuse. Many participants felt that the informed consent process failed to adequately capture the reality of the potential side effects they would later face.
While medical professionals maintain that the procedure remains a viable option for treatment-resistant conditions, the authors of this new research are calling for a re-examination of current standards. Their goal is to push for updated regulations and to bring patient accounts into the public discourse. They emphasize that when patients are labeled with certain diagnoses, their own reports of their experiences are often dismissed, leading to a cycle where the voices of those receiving the care are marginalized.